ENGN peer analysis
enGene Therapeutics (ENGN) against its competitors: price, today's move, 1-year return and market value side by side.
ENGN and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ACIU AC Immune | $2.26 | -1.31% | -33.33% | $230.01M |
| ALT Altimmune | $1.77 | -8.55% | -58.76% | $343.32M |
| AMRN Amarin | $11.71 | -0.34% | -27.22% | $5.18B |
| ANNX Annexon | $4.00 | -4.42% | 34.85% | $764.01M |
| ANRO Alto Neuroscience | $32.12 | 3.11% | 139.70% | $1.26B |
| CLLS Cellectis | $1.38 | 24.32% | -62.90% | $139.01M |
| DBVT DBV Technologies | $11.83 | -0.42% | -11.32% | $282.99M |
| KRRO Korro Bio | $14.10 | -2.15% | -57.01% | $203.36M |
| LRMR Larimar Therapeutics | $2.70 | -1.10% | -25.62% | $280.48M |
| SLN Silence Therapeutics | $19.80 | 0.15% | 194.64% | $935.23M |
| ENGN enGene Therapeutics | $2.28 | 26.67% | -74.15% | $152.80M |
- ENGN's peers: ACIU (AC Immune), ALT (Altimmune), AMRN (Amarin), ANNX (Annexon), ANRO (Alto Neuroscience), CLLS (Cellectis), DBVT (DBV Technologies), KRRO (Korro Bio).
Updated 2026-11-12 17:46 UTC